David Vaux

Corporate Officer/Principal at The Walter & Eliza Hall Institute of Medical Research

Commercial Services

Consumer Services

Profile

David Vaux is currently the Deputy Director-Science Integrity & Ethics at The Walter & Eliza Hall Institute of Medical Research.
He has an undergraduate and doctorate degree from the University of Melbourne.

David Vaux active positions

Companies	Position	Start
The Walter & Eliza Hall Institute of Medical Research The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia.	Corporate Officer/Principal	2011-08-07

All active positions of David Vaux

Training of David Vaux

University of Melbourne

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Vaux's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
The Walter & Eliza Hall Institute of Medical Research The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia.	Commercial Services